893574-11-3 Usage
Chemical structure
A derivative of 2-propanol with a nitrobenzylamine group attached to the nitrogen atom.
Appearance
It is likely a colorless to pale yellow liquid or solid, depending on the conditions.
Solubility
It is likely soluble in organic solvents such as ethanol, methanol, and dichloromethane.
Stability
It is stable under normal laboratory conditions, but should be stored away from light, heat, and moisture.
Reactivity
It may react with strong acids, strong bases, and reducing agents.
Uses
a. As a reagent in organic synthesis.
b. As a building block for the preparation of various pharmaceuticals and other chemical compounds.
c. Potential applications in the field of medicine and drug development.
d. As a research tool in biochemistry and molecular biology.
Safety
It should be handled with care, as it may be toxic or harmful if ingested, inhaled, or absorbed through the skin. It should be used in a well-ventilated area and proper personal protective equipment (PPE) should be worn.
Regulatory status
It may be subject to regulation as a hazardous chemical, depending on the jurisdiction and the specific use case.
Environmental impact
It may be harmful to aquatic life and should be disposed of properly to minimize environmental impact.
Check Digit Verification of cas no
The CAS Registry Mumber 893574-11-3 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,9,3,5,7 and 4 respectively; the second part has 2 digits, 1 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 893574-11:
(8*8)+(7*9)+(6*3)+(5*5)+(4*7)+(3*4)+(2*1)+(1*1)=213
213 % 10 = 3
So 893574-11-3 is a valid CAS Registry Number.
893574-11-3Relevant academic research and scientific papers
Adamczyk,Grote,Mattingly
, p. 753 - 758 (1995)
Digoxin dialdehyde reportedly undergoes reductive amination with primary amines to form a perhydro-1,4-oxazepine; however, no structural proof has been published to substantiate this belief. A digoxin perhydro-1,4-oxazepine derivative has been isolated from the reductive amination of digoxin dialdehyde and its structure determined by mass spectroscopy and NMR measurements. Comparison of the NMR, mass spectroscopy, and HPLC of two compounds obtained from the degradation of the digoxin reductive amination product with synthesized perhydro-1,4-oxazepine diastereomers showed them to be identical. We conclude that, under appropriate conditions, reductive amination products can be obtained, but caution that other products may be produced as well, especially under the conditions of bioconjugation to proteins.
